Advanced Technology Ventures
Founded in 1979, Advanced Technology Ventures (ATV) is a bi-coastal venture capital firm with more than $1.5 billion in capital under management. ATV works closely with entrepreneurial teams across several markets, including communications, IT infrastructure, software and services, and healthcare, to build emerging-growth business ventures into market leaders. For more information, visit www.atvcapital.com.
Bessemer Venture Partners
Bessemer Venture Partners was founded in 1911 and is one of the oldest venture capital firms in the US. Since its inception, Bessemer has built a global presence with offices in Silicon Valley, New York, Massachusetts, Israel, China, and India. Bessemer’s portfolio spans a broad range of industries and has included some of the most successful investment opportunities including Affymax, Centocor, Ingersoll Rand, Sirtris Pharmaceuticals, Skype, and Staples, Inc., among others. For more information, visit www.bvp.com
Realizing entrepreneurial innovation is the mission of Flagship Ventures. The firm operates through two synergistic units: VentureLabs™ which invents and launches transformative companies, and Venture Capital, which finances and develops innovative, early-stage companies. Founded in 2000, and based in Cambridge, Massachusetts, Flagship Ventures manages over $900 million in capital. The Flagship team is active in three principal business sectors: therapeutics, health technologies and sustainability/clean technology. Past successful Flagship portfolio companies include: Accuri Cytometers (acquired by Becton, Dickinson and Company), Adnexus (acquired by Bristol-Myers Squibb), Hypnion (acquired by Eli Lilly), Agios (NASDAQ: AGIO), AVEO (NASDAQ: AVEO), BG Medicine (NASDAQ: BGMD), Receptos (NASDAQ: RCPT), Tetraphase (NASDAQ: TTPH), and Morphotek (acquired by Eisai). Additional notable portfolio companies include: Affinnova, BIND Therapeutics, Joule Unlimited, Quanterix, and Moderna Therapeutics. For more information, please visit www.flagshipventures.com.
MPM Capital is the world's largest life science-dedicated venture investor. With committed capital under management in excess of $2.5 billion, MPM Capital is uniquely structured to invest globally in healthcare innovation. MPM invests in biotechnology, specialty pharma, medical technology, and related companies that provide innovative medical products and requisite services to the healthcare industry. MPM BioEquities invests dynamically between late stage private and early stage public companies. For more information, visit www.mpmcapital.com
OrbiMed is a leading investment firm dedicated exclusively to the healthcare sector. With $7 billion in assets under management, OrbiMed invests globally across the spectrum of healthcare companies, from venture capital start-ups to large multinational companies. OrbiMed’s team manages a series of private equity funds, public equity funds, royalty and debt funds, and other investment vehicles. For more information visit www.orbimed.com.
Polaris Venture Partners
Established in 1996, with offices in Waltham and Seattle, Polaris has over $3 billion under management. Polaris Venture Partners have helped build numerous market leading companies, including Accordant Health Services, Advanced Inhalation Research, Akamai Technologies, Allaire, Alnylam Pharmaceuticals, American Superconductor, Aspect Medical Systems, Avici Systems, Centra Software, Classifieds2000, deCODE genetics, Exchange.com, Matrics, Microbia, Momenta Pharmaceuticals, Paradigm Genetics, Powersoft, PSCI, SolidWorks and TransForm Pharmaceuticals. More information about Polaris Venture Partners is available at www.polarisventures.com.
QVT originated as a non-traditional proprietary trading group inside an investment bank. Their core team has spent over 10 years working together to develop and implement innovative, fundamental and quantitatively-oriented trading strategies, many of which make extensive use of proprietary software developed by our most senior members. With over $6 billion under management, QVT is one of the largest hedge fund management companies launched in recent years. For more information, visit www.qvt.com
Sutter Hill Ventures
Founded in 1964, Sutter Hill Ventures is one of Silicon Valley's original venture capital firms. Healthcare companies backed by Sutter Hill include Amylin, Cor Therapeutics, Molecular Devices, Neurex, Omnicell and Praecis. For more information, visit www.shv.com.
Venrock is a leading venture capital firm with offices in Palo Alto, CA; New York, NY; and Cambridge, MA. Originally established as the venture capital arm of the Rockefeller family, Venrock continues an eight-decade tradition of partnering with entrepreneurs to establish successful, enduring companies. With a primary focus on technology, healthcare, and energy, portfolio companies have included Adify, Adnexus Therapeutics, Apple Computer, Athenahealth, Centocor, Check Point Software, DoubleClick, Gilead Sciences, Idec Pharmaceuticals, Illumina, Intel, Millennium Pharmaceuticals, Sirna Therapeutics, StrataCom, and Vontu. For more information, please visit Venrock’s website at www.venrock.com and follow the firm on Twitter at @venrock.